UniProt ID | MK07_HUMAN | |
---|---|---|
UniProt AC | Q13164 | |
Protein Name | Mitogen-activated protein kinase 7 | |
Gene Name | MAPK7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 816 | |
Subcellular Localization | Cytoplasm. Nucleus. Nucleus, PML body. Translocates to the nucleus upon activation. | |
Protein Description | Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction.. | |
Protein Sequence | MAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPSGDCAMESPPPAPPPCPGPAPDTIDLTLQPPPPVSEPAPPKKDGAISDNTKAALKAALLKSLRSRLRDGPSAPLEAPEPRKPVTAQERQREREEKRRRRQERAKEREKRRQERERKERGAGASGGPSTDPLAGLVLSDNDRSLLERWTRMARPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQPTGPQPQSAGSTSGPVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPPGLPGSSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPLPPVFSGTPKGSGAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSASLLADWLEGHGMNPADIESLQREIQMDSPMLLADLPDLQDP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEPLKEED ------CCCCCCCCC | 27.41 | - | |
6 | Sumoylation | --MAEPLKEEDGEDG --CCCCCCCCCCCCC | 70.54 | - | |
14 | Phosphorylation | EEDGEDGSAEPPGPV CCCCCCCCCCCCCCC | 41.61 | 28348404 | |
22 | Sumoylation | AEPPGPVKAEPAHTA CCCCCCCCCCCCCHH | 50.60 | - | |
28 | Phosphorylation | VKAEPAHTAASVAAK CCCCCCCHHHHHHHH | 26.48 | 12628002 | |
31 | Phosphorylation | EPAHTAASVAAKNLA CCCCHHHHHHHHHHH | 15.15 | 21924351 | |
35 | Acetylation | TAASVAAKNLALLKA HHHHHHHHHHHHHHH | 42.64 | 19608861 | |
70 | Phosphorylation | NGAYGVVSSARRRLT CCHHHHHHHHHHHHC | 18.84 | - | |
71 | Phosphorylation | GAYGVVSSARRRLTG CHHHHHHHHHHHHCC | 17.74 | - | |
84 | Acetylation | TGQQVAIKKIPNAFD CCCEEEEECCCCHHH | 34.61 | 25953088 | |
110 | Ubiquitination | LKILKHFKHDNIIAI HHHHHHCCCCCEEEE | 50.17 | - | |
118 | Ubiquitination | HDNIIAIKDILRPTV CCCEEEEEHHHCCCC | 29.69 | - | |
184 | Ubiquitination | QVIHRDLKPSNLLVN EEECCCCCHHHEEEC | 51.17 | - | |
209 | Phosphorylation | GMARGLCTSPAEHQY CCCCCCCCCHHHHHH | 42.67 | 26356563 | |
210 | Phosphorylation | MARGLCTSPAEHQYF CCCCCCCCHHHHHHH | 22.55 | 28152594 | |
216 | Phosphorylation | TSPAEHQYFMTEYVA CCHHHHHHHHHHHHH | 9.38 | 28152594 | |
218 | Phosphorylation | PAEHQYFMTEYVATR HHHHHHHHHHHHHHC | 2.07 | 11739740 | |
219 | Phosphorylation | AEHQYFMTEYVATRW HHHHHHHHHHHHHCH | 17.79 | 22322096 | |
220 | Phosphorylation | EHQYFMTEYVATRWY HHHHHHHHHHHHCHH | 26.65 | 11739740 | |
221 | Dephosphorylation | HQYFMTEYVATRWYR HHHHHHHHHHHCHHC | 6.04 | 12042304 | |
221 | Phosphorylation | HQYFMTEYVATRWYR HHHHHHHHHHHCHHC | 6.04 | 27273156 | |
224 | Phosphorylation | FMTEYVATRWYRAPE HHHHHHHHCHHCCHH | 16.22 | 21082442 | |
267 | Phosphorylation | QLFPGKNYVHQLQLI CCCCCCCHHHHHHHH | 11.64 | 24043423 | |
280 | Phosphorylation | LIMMVLGTPSPAVIQ HHHHHHCCCCHHHHH | 19.21 | 24043423 | |
282 | Phosphorylation | MMVLGTPSPAVIQAV HHHHCCCCHHHHHHH | 25.90 | 24043423 | |
300 | Phosphorylation | RVRAYIQSLPPRQPV HHHHHHHCCCCCCCC | 33.03 | 24719451 | |
322 | Phosphorylation | GADRQALSLLGRMLR CCCHHHHHHHHHHHH | 25.27 | 21924351 | |
337 | Phosphorylation | FEPSARISAAAALRH CCCHHHHHHHHHHHC | 13.30 | 29691806 | |
378 | Ubiquitination | ALTRERIKEAIVAEI HHCHHHHHHHHHHHH | 47.52 | - | |
421 | Phosphorylation | CPDVEMPSPWAPSGD CCCCCCCCCCCCCCC | 31.59 | 21924351 | |
433 | Phosphorylation | SGDCAMESPPPAPPP CCCCCCCCCCCCCCC | 29.62 | 21924351 | |
472 | Phosphorylation | PKKDGAISDNTKAAL CCCCCCCCHHHHHHH | 25.03 | 21924351 | |
476 | Ubiquitination | GAISDNTKAALKAAL CCCCHHHHHHHHHHH | 37.61 | - | |
480 | Methylation | DNTKAALKAALLKSL HHHHHHHHHHHHHHH | 27.21 | - | |
485 | Methylation | ALKAALLKSLRSRLR HHHHHHHHHHHHHHC | 48.58 | - | |
486 | Phosphorylation | LKAALLKSLRSRLRD HHHHHHHHHHHHHCC | 29.05 | 24117733 | |
496 | Phosphorylation | SRLRDGPSAPLEAPE HHHCCCCCCCCCCCC | 48.31 | 22267842 | |
552 | Phosphorylation | AGASGGPSTDPLAGL CCCCCCCCCCCCCCE | 49.03 | 27732954 | |
553 | Phosphorylation | GASGGPSTDPLAGLV CCCCCCCCCCCCCEE | 44.78 | 27732954 | |
562 | Phosphorylation | PLAGLVLSDNDRSLL CCCCEECCCCCHHHH | 27.21 | 27732954 | |
567 | Phosphorylation | VLSDNDRSLLERWTR ECCCCCHHHHHHHHH | 39.92 | 20667468 | |
584 | Phosphorylation | RPAAPALTSVPAPAP CCCCCCCCCCCCCCC | 29.77 | 20058876 | |
594 | Phosphorylation | PAPAPAPTPTPTPVQ CCCCCCCCCCCCCCC | 41.73 | 19664994 | |
707 | Phosphorylation | PQSSMSESPDVNLVT CCCCCCCCCCHHHHH | 21.06 | 21924351 | |
718 | Phosphorylation | NLVTQQLSKSQVEDP HHHHHHHHHHHCCCC | 26.39 | 21924351 | |
720 | Phosphorylation | VTQQLSKSQVEDPLP HHHHHHHHHCCCCCC | 35.76 | 25159151 | |
731 | Phosphorylation | DPLPPVFSGTPKGSG CCCCCCCCCCCCCCC | 41.83 | 25159151 | |
733 | Phosphorylation | LPPVFSGTPKGSGAG CCCCCCCCCCCCCCC | 22.19 | 19664994 | |
737 | Phosphorylation | FSGTPKGSGAGYGVG CCCCCCCCCCCCCCC | 31.43 | 26074081 | |
754 | Phosphorylation | LEEFLNQSFDMGVAD HHHHHHHCCCCCCCC | 23.34 | 21924351 | |
770 | Phosphorylation | PQDGQADSASLSASL CCCCCCCCHHHHHHH | 23.83 | 21924351 | |
772 | Phosphorylation | DGQADSASLSASLLA CCCCCCHHHHHHHHH | 27.15 | 21924351 | |
774 | Phosphorylation | QADSASLSASLLADW CCCCHHHHHHHHHHH | 17.20 | 21924351 | |
776 | Phosphorylation | DSASLSASLLADWLE CCHHHHHHHHHHHHH | 22.12 | 21924351 | |
803 | Phosphorylation | QREIQMDSPMLLADL HHHHHCCCCCCCCCC | 13.58 | 20667468 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
28 | T | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
219 | T | Phosphorylation | Kinase | MAP2K5 | Q13163 | GPS |
221 | Y | Phosphorylation | Kinase | MAP2K5 | Q13163 | GPS |
421 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
433 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
496 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
496 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
731 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
733 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
733 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
733 | T | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
770 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
772 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
774 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
219 | T | Phosphorylation |
| 22869143 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MK07_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-221; SER-731 ANDTHR-733, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-720 AND THR-733, ANDMASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-221, AND MASSSPECTROMETRY. |